Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

GLP-1 RAs may lower long-term mortality risk in AIS patients
16 Feb 2026
bởiStephen Padilla
The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) appears to contribute to a long-term reduced risk of death in patients with acute ischaemic stroke (AIS), suggests a study. However, less than 1 percent of these individuals have been prescribed GLP-1 RAs upon discharge.








